The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Liraglutide is a glucagon-like peptide-1 (GLP-1) analog marketed for the treatment of type 2 diabetes. Besides lowering blood glucose, liraglutide also reduces body weight. It is not fully understood how liraglutide induces weight loss or to what degree liraglutide acts directly in the brain. Here,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Secher, Anna, Jelsing, Jacob, Baquero, Arian F., Hecksher-Sørensen, Jacob, Cowley, Michael A., Dalbøge, Louise S., Hansen, Gitte, Grove, Kevin L., Pyke, Charles, Raun, Kirsten, Schäffer, Lauge, Tang-Christensen, Mads, Verma, Saurabh, Witgen, Brent M., Vrang, Niels, Bjerre Knudsen, Lotte
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4215190/
https://ncbi.nlm.nih.gov/pubmed/25202980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI75276
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak